Tracking non-relapse mortality after CAR T cell therapy

被引：0
|
作者：
Blumenberg, Viktoria [1 ,2 ]
Maus, Marcela V. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Cellular Immunotherapy Program, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
NATURE MEDICINE | 2024年 / 30卷 / 09期
关键词：
LYMPHOMA;
D O I：
10.1038/s41591-024-03212-2
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Infections account for the highest number of non-relapse-related deaths after CAR T cell therapy, underscoring the necessity for clinical risk-mitigating strategies and a deeper understanding of CAR T cell-related cytopenia.
引用
收藏
页码：2413 / 2414
页数：2
相关论文
共 50 条
  • [41] Early Prognostic Biomarkers of Non-Relapse Mortality in Allogeneic Mismatched Unrelated Hematopoietic Cell Transplantation
    Wang, Trent
    Crawford, Anna
    Fu, Denggang
    Hill, Elizabeth
    Jimenez, Antonio M. Jimenez
    Komanduri, Krishna V.
    Paczesny, Sophie
    BLOOD, 2023, 142
  • [42] Higher Non-Relapse Mortality with BuCyVP Compared to BuCy In Allogeneic Hematopoietic Stem Cell Transplant
    Duong, Hien
    Bolwell, Brian J.
    Rybicki, Lisa
    Kalaycio, Matt
    Andresen, Steven
    Sobecks, Ronald
    Dean, Robert
    Sweetenham, John William
    Tench, Shawnda
    Copelan, Edward A.
    BLOOD, 2010, 116 (21) : 574 - 574
  • [43] Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia
    Schetelig, J
    Thiede, C
    Bornhäuser, M
    Schwerdtfeger, R
    Kiehl, M
    Beyer, J
    Kröger, N
    Hensel, M
    Scheffold, C
    Ho, AD
    Kienast, J
    Neubauer, A
    Zander, AR
    Fauser, AA
    Ehninger, G
    Siegert, W
    ANNALS OF HEMATOLOGY, 2002, 81 : S47 - S48
  • [44] The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation
    Joshua A. Fein
    Avichai Shimoni
    Myriam Labopin
    Noga Shem-Tov
    Ronit Yerushalmi
    Hila Magen
    Nadav Furie
    Eli Kopel
    Ivetta Danylesko
    Arnon Nagler
    Roni Shouval
    Leukemia, 2018, 32 : 1787 - 1794
  • [45] Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients
    Solano, Carlos
    Gimenez, Estela
    Luis Pinana, Jose
    Albert, Eliseo
    Vinuesa, Victor
    Carlos Hernandez-Boluda, Juan
    Amat, Paula
    Navarro, David
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (04)
  • [46] Optimising patient selection for allogeneic stem cell transplantation: prediction of non-relapse mortality and survival
    Pavlu, J.
    Rezvani, K.
    Kishore, B.
    Chakrabartty, J.
    Shah, R.
    Auner, H. W.
    Milojkovic, D.
    Marin, D.
    Rahemtulla, A.
    MacDonald, D. H.
    Kanfer, E. J.
    Dazzi, F.
    Goldman, J. M.
    Apperley, J. F.
    Szydlo, R. M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S27 - S28
  • [47] Pre-transplant weight loss predicts non-relapse mortality and relapse rates in patients with myelodysplastic syndrome after allogeneic stem cell transplantation
    Radujkovic, A.
    Becker, N.
    Benner, A.
    Dietrich, S.
    Penack, O.
    Platzbecker, U.
    Stoelzel, F.
    Bornhaeuser, M.
    Hegenbart, U.
    Ho, A. D.
    Dreger, P.
    Luft, T.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S73 - S73
  • [48] INCREASED RISK FOR NON-RELAPSE MORTALITY IN PATIENTS WITH IRON OVERLOAD UNDERGOING STEM CELL TRANSPLANTATION
    Gil, L. Anna
    Kozlowska-Skrzypczak, M.
    Mackowiak, K.
    Czyz, A.
    Dytfeld, D.
    Lojko-Dankowska, A.
    Matuszak, M.
    Nowicki, A.
    Komarnicki, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S268 - S269
  • [49] The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation
    Fein, Joshua A.
    Shimoni, Avichai
    Labopin, Myriam
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Magen, Hila
    Furie, Nadav
    Kopel, Eli
    Danylesko, Ivetta
    Nagler, Arnon
    Shouval, Roni
    LEUKEMIA, 2018, 32 (08) : 1787 - 1794
  • [50] Development and Validation of a Concise Objectifiable Risk Evaluation Score for Non-Relapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation
    Weise, Gunnar
    Massoud, Radwan
    Krause, Rolf
    Heidenreich, Silke
    Janson, Dietlinde
    Klyuchnikov, Evgeny
    Wolschke, Christine
    Zeck, Gaby
    Kroeger, Nicolaus
    Ayuk, Francis
    CANCERS, 2024, 16 (03)
12345